RHEE, INA P.,KIM, JEONG,HUSENI, MAHRUKH,STEFANICH, ERIC,SUKUMARAN, SID,LI, CHI-CHUNG
申请号：
CA2985483
公开号：
CA2985483A1
申请日:
2016.06.07
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The invention provides methods of treating or delaying progression of cancer in an individual comprising administering to the individual an anti-human OX40 agonist antibody. In some embodiments, the antibody is administered in a dose selected from about 0.2mg, about 0.8mg, about 3.2mg, about 12mg, about 40mg, about 80mg, about 130mg, about 160mg, about 300mg, about 320mg, about 400mg, about 600mg, and about 1200mg.
